Cleared Abbreviated

K163084 - Merit Coronary Control Syringe

K163084 is an FDA 510(k) clearance for Merit Coronary Control Syringe, manufactured by Merit Medical Systems, Inc.. The device is a Class 2 Cardiovascular device with product code DXT cleared through the Abbreviated 510(k) pathway after a 224-day FDA review.

K163084 · Merit Medical Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
224d
Days
Class 2
Risk

K163084 is an FDA 510(k) clearance for the Merit Coronary Control Syringe. Classified as Injector And Syringe, Angiographic (product code DXT), Class II - Special Controls.

Submitted by Merit Medical Systems, Inc. (South Jordan, US). The FDA issued a Cleared decision on June 15, 2017 after a review of 224 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1650 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Merit Medical Systems, Inc. devices

FDA 510(k) Submission Details - K163084

510(k) Number K163084 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 2016
Decision Date June 15, 2017
Days to Decision 224 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
99d slower than avg
Panel avg: 125d · This submission: 224d
Pathway characteristics
Standards-based clearance path.

DXT Device Classification - Class 2, Special Controls

Product Code DXT Injector And Syringe, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXT Injector And Syringe, Angiographic

All 182
Devices cleared under the same product code (DXT) and FDA review panel - the closest regulatory comparables to K163084.
Disposable High Pressure Syringe
K170279 · Union Medical Shenzhen Co., Ltd. · Dec 2017
CT Syringe for Stellant Injectors (with & without Spikes, Prime Tubes, & Fill Tubes), CT Syringe Dual Pack for Stellant Injectors (with & without Spikes, Prime Tubes, & Fill Tubes), Single Fascia and Ram Tip, Dual Fascia and Ram Tip
K170431 · Coeur, Inc. · Aug 2017
Smart Syringe
K171698 · Osprey Medical, Inc. · Jul 2017
DyeVert Plus Contrast Reduction System, DyeVert NG Contrast Reduction System
K171217 · Osprey Medical, Inc. · May 2017
DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring System
K163054 · Osprey Medical, Inc. · Mar 2017
Ecomed Disposable Angiographic Syringes
K162088 · Ecomed Solutions, LLC · Jan 2017